Portfolio (Quarterly)
Guide ↗
GF FUND MANAGEMENT CO. LTD.
· CIK 0002057060| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 481 | JANX | Janux Therapeutics Inc | Healthcare | 1,289.0 | $20K | — | NEW | — | $15.36 | +6.1% |
| 482 | VOR | Vor BioPharma Inc | Healthcare | 1,072.0 | $20K | — | NEW | — | $18.41 | +0.6% |
| 483 | SANA | Sana Biotechnology Inc | Healthcare | 5,637.0 | $20K | — | NEW | — | $3.49 | -15.6% |
| 484 | RLJ | RLJ Lodging Trust | Real Estate | 1,659.0 | $20K | — | NEW | — | $11.85 | -5.5% |
| 485 | ABUS | Arbutus Biopharma Corp | Healthcare | 4,071.0 | $20K | — | NEW | — | $4.80 | +1.0% |
| 486 | — | Solid Biosciences Inc | — | 1,946.0 | $19K | — | NEW | — | $9.99 | — |
| 487 | AMPH | Amphastar Pharmaceuticals Inc | Healthcare | 963.0 | $19K | — | NEW | — | $20.18 | +29.5% |
| 488 | REPL | Replimune Group Inc | Healthcare | 1,750.0 | $19K | — | NEW | — | $11.07 | +11.7% |
| 489 | MRVI | Maravai LifeSciences Holdings | Healthcare | 3,099.0 | $19K | — | NEW | — | $6.24 | +21.8% |
| 490 | TBPH | Theravance Biopharma Inc | Healthcare | 1,076.0 | $18K | — | NEW | — | $17.00 | +0.2% |
| 491 | GRFS | Grifols SA | Healthcare | 2,582.0 | $18K | — | NEW | — | $7.08 | +3.8% |
| 492 | PHAT | Phathom Pharmaceuticals Inc | Healthcare | 1,669.0 | $18K | — | NEW | — | $10.85 | -32.7% |
| 493 | ANNX | Annexon Inc | Healthcare | 3,065.0 | $18K | — | NEW | — | $5.71 | -36.3% |
| 494 | DSGN | Design Therapeutics Inc | Healthcare | 1,209.0 | $17K | — | NEW | — | $14.47 | -16.2% |
| 495 | GERN | Geron Corp | Healthcare | 13,506.0 | $17K | — | NEW | — | $1.28 | -1.6% |
| 496 | — | Zevra Therapeutics Inc | — | 1,194.0 | $17K | — | NEW | — | $14.34 | — |
| 497 | SPRY | ARS Pharmaceuticals Inc | Healthcare | 2,094.0 | $17K | — | NEW | — | $8.01 | -49.1% |
| 498 | UMH | UMH Properties Inc | Real Estate | 1,097.0 | $17K | — | NEW | — | $15.14 | +1.7% |
| 499 | AAT | American Assets Trust Inc | Real Estate | 665.0 | $16K | — | NEW | — | $24.69 | -12.6% |
| 500 | CTMX | CytomX Therapeutics Inc | Healthcare | 4,302.0 | $16K | — | NEW | — | $3.75 | -28.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
70.8%
Consumer Cyclical
9.0%
Communication Services
6.0%
Healthcare
4.5%
Consumer Defensive
3.9%
Industrials
1.9%
Energy
1.8%
Utilities
0.8%
Financial Services
0.6%
Basic Materials
0.6%